Acute chest pain (ACP) is a common symptom that can indicate a range of conditions, from benign to life-threatening. The clinical approach to ACP requires a thorough understanding of differential diagnoses, relevant investigations, and appropriate management strategies.
The initial assessment of a patient presenting with ACP should focus on identifying immediate life-threatening conditions such as myocardial infarction (MI) or aortic dissection. Vital signs, physical examination, and a 12-lead ECG should be performed rapidly. The patient's history, including the characteristics of the pain and risk factors for coronary artery disease, can provide valuable diagnostic clues.
ACP can arise from cardiac, gastrointestinal, pulmonary, musculoskeletal, and psychiatric conditions. Cardiac causes include MI, angina, and pericarditis. Gastrointestinal conditions such as gastroesophageal reflux disease and peptic ulcer disease can mimic cardiac pain. Pulmonary causes include pulmonary embolism and pneumonia. Musculoskeletal and psychiatric causes are often considered once life-threatening conditions have been ruled out.
Investigations should be guided by the suspected diagnosis. For suspected MI, cardiac biomarkers (troponin) and repeated ECGs are essential. Chest radiography, computed tomography, and endoscopy may be indicated for pulmonary and gastrointestinal causes, respectively.
Management depends on the underlying cause. Immediate reperfusion therapy is critical in MI, while aortic dissection requires surgical intervention. Gastrointestinal, pulmonary, musculoskeletal, and psychiatric causes are managed according to their specific treatment guidelines.
The clinical approach to ACP is challenging due to the wide range of potential causes. A systematic approach, guided by a thorough history, physical examination, and appropriate investigations, can help healthcare professionals accurately diagnose and manage these patients. Ongoing education and training in this area are crucial to ensure the best patient outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation